How GLP-1 Policy Fits Into Trump’s Greenland Strategy, And Five Other Health Tech Developments

What does a pharmaceutical company have to do with U.S. national security? Perhaps more than meets the eye, based on President Trump’s negotiating style, which often involves utilizing leverage to weaken the other side’s bargaining position….

Continue Reading